March 2, 2021 A patient getting a COVID-19 jab
Drawing from the 2030 Agenda for Sustainable Development (AfSD) vision to ‘leave no one behind’, particularly low-income countries, a research report on COVID-19 vaccines and treatments, contends that more big pharmaceutical companies need to buy into the COVAX initiative.
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a global initiative aimed at equitable access to COVID-19 vaccines led by the Global Alliance for Vaccines and Immunization, the World Health Oganization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and others.
The research:
“COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs” authored by Prof Godwell Nhamo, Dr David Chikodzi, Hlengiwe Precious Kunene and Nthivhiseni Mashula, says from the procurement and distribution of COVID-19 personal protective equipment (PPE) and ventilators to the outlook of possible vaccine
Pasha 90: How COVID-19 has hit the tourism sector africaleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from africaleader.com Daily Mail and Mail on Sunday newspapers.